Navigation Links
AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy
Date:5/20/2013

style-type:disc" type="disc">
  • A more than 30 percent albuminuria reduction was observed in 51 and 55 percent of the atrasentan subjects, respectively (P=0.001).ii
  • Changes in estimated glomerular filtration rate (eGFR), another important measure of kidney function, were measured  compared to placebo in both groups (0.75mg= -0.81/min/1.73m2; p=0.412 and 1.25mg= -0.91 ml/min/1.73m2; p=0.355), and did not change significantly compared to placebo.ii
  • In the Phase 2b studies, the observed adverse events were similar among the three treatment and placebo groups.  The most commonly observed adverse events included peripheral edema (35 percent in 0.75mg arm, 42 percent in 1.25 mg arm vs. 42 percent on placebo), diarrhea and constipation (13 percent in 0.75mg arm, 21 percent in 1.25 mg arm vs. 14 percent on placebo).  There were no significant differences in the rate of peripheral edema or diarrhea and constipation among the treatment and placebo arms.ii 

    A small percentage of subjects discontinued the study due to adverse events (8 percent on 0.75 mg, 15 percent on 1.25mg vs. 0 on placebo), with edema as the most commonly cited reason.ii

    Importantly, the study concluded that the 0.75 mg dose of atrasentan administered orally once daily showed the best efficacy-safety balance, informing the dosing of atrasentan selected for further investigation in the Phase 3 clinical study.ii

    About SONAR Study

    SONAR is a randomized, double-blind, parallel, placebo-controlled, multicenter study designed to assess the effects of atrasentan (0.75 mg administered orally once a day) on renal outcomes in patients with type 2 diabetic nephropathy (diabetic kidney disease) while they continue to be treated with the current standard of care: the maximum tolerated labeled daily dose of a RAS inhibitor, such as an ACE inhibitor or an ARB, and a diuret
    '/>"/>

    SOURCE AbbVie
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. AbbVie Named to S&P 500 Dividend Aristocrat Index
    2. AbbVie Issues Inaugural Full-Year Outlook for 2013
    3. AbbVie to Present at Barclays Global Health Care Conference
    4. Receptos Licenses Anti-Interleukin-13 Antibody from AbbVie for Phase 2 Development in Orphan Disease
    5. AbbVie to Host First-Quarter Earnings Conference Call
    6. AbbVie Reports First-Quarter 2013 Financial Results
    7. AbbVie CF Scholarship Application Now Available for Exceptional Undergraduate and Graduate Students with Cystic Fibrosis
    8. AbbVies Investigational HCV Regimen Receives Breakthrough Therapy Designation from the U.S. Food and Drug Administration
    9. AbbVie to Present at Bank of America Merrill Lynch 2013 Health Care Conference
    10. AbbVie and Alvine to Collaborate on Investigational Oral Therapy for Celiac Disease
    11. AbbVie to Present Data on Investigational Anti-Cancer Compounds at American Society of Clinical Oncology Annual Meeting
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/31/2015)... 2015  Seeger Weiss LLP is reporting that on July ... letter to C.R. Bard, the manufacturer of Inferior vena ... correct violations the agency found at two of Bard,s facilities. ... FDA cited them during Inspectional Observations that occurred on November ... Tempe, AZ , location and on October 6, 2014, ...
    (Date:7/31/2015)... RnRMarketResearch.com adds Syringes and ... that provides an overview of syringes and needles ... in-house databases, secondary and primary research. ... pipeline spread across 124 pages, talking about 13 ... 5 figures is now available at http://www.rnrmarketresearch.com/syringes-and-needles-pipeline-review-2015-market-report.html ...
    (Date:7/31/2015)... According to a new market research report " Sterilization ... Filtration, E-beam, Gamma), Services (Onsite & Offsite), Consumables (Indicators, Detergents, ... 2020", published by MarketsandMarkets, The Sterilization Equipment Market is expected ... CAGR of 7.6%.from 2015 to 2020. Browse ... and 37 F igures spread ...
    Breaking Medicine Technology:Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3Syringes and Needles Market Products Pipeline Review 2015 Report 2Syringes and Needles Market Products Pipeline Review 2015 Report 3Syringes and Needles Market Products Pipeline Review 2015 Report 4Syringes and Needles Market Products Pipeline Review 2015 Report 5Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 2Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 3Sterilization Equipment Market is Expected to Reach USD 6.1 Billion by 2020 4
    ... NEW BRUNSWICK, N.J., Jan. 14, 2011 McNeil Consumer Healthcare ... JNJ ) company, in July 2010 submitted to the ... a commitment to restore its operations to the level of ... Johnson companies. As part of this commitment, McNeil undertook a ...
    ... 2011 New clinical research data suggests that [18F] ... by physicians and provide accurate identification of beta amyloid ... to Alzheimer,s Disease (AD).  Flutemetamol, a GE Healthcare Positron ... development, is being studied to identify the uptake of ...
    Cached Medicine Technology:Johnson & Johnson Provides Update on McNeil Consumer Healthcare Remediation; Announces Completion of Internal Assessment Phase of Comprehensive Action Plan 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 2GE Healthcare Presents Flutemetamol Data for Detection of Amyloid Plaque Linked to Alzheimer's Disease 3
    (Date:7/31/2015)... ... 31, 2015 , ... Girl Scouts of Historic Georgia and Peach State Health ... Scout "Be a Friend First" program. Representatives from Peach State Health Plan presented a ... Health Plan and our parent company, Centene Corporation, are dedicated to raising anti-bullying awareness. ...
    (Date:7/31/2015)... ... July 31, 2015 , ... The 2015 ALS Ice Bucket Challenge will officially ... Boston Red Sox honor Ice Bucket co-founders Pat Quinn and Pete Frates, the ALS ... further collaborative efforts among the ALS organizations to find treatments and cures for the ...
    (Date:7/31/2015)... ... 31, 2015 , ... Recently, ZKB filed another federal lawsuit ... (Case No. 3:15-cv-00397) involving the Implanon® contraceptive implant . , As described ... Implanon® implants, inability to locate the implants, unsuccessful and invasive attempts at implant ...
    (Date:7/31/2015)... New York, NY and Rockport, ME (PRWEB) , ... July 31, 2015 , ... The ... this photo op. , Glancing out of the window, he recalled that his equipment ... 215 Chrystie Street tower, he jumped out of bed. , The photo speaks ...
    (Date:7/31/2015)... ... July 31, 2015 , ... Patients with higher levels ... a study published today in Nature Communications and led by researchers from the Icahn ... that variations in the gene RTN1 led to greater production of the related RNT1 ...
    Breaking Medicine News(10 mins):Health News:Peach State Health Plan Presents $10,000 Check for “Be a Friend First” Anti-Bullying Program to Local Girl Scouts 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 2Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 3Health News:Major League Baseball Joins MDA and Fourteen Other ALS Organizations to Launch ALS Ice Bucket Challenge 2015 4Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 2Health News:Can Implanon® (Etonogestrel Implant) Go Missing? Zoll, Kranz & Borgess, LLC Files Another Lawsuit on Behalf of Women with Lost or Migrated Implanon® Implants 3Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 2Health News:Mount Sinai Researchers Find Key Gene Drives Kidney Disease Severity 3
    ... and LOS ANGELES, March 16 /PRNewswire-Asia-FirstCall/ -- China ... Company") (OTC Bulletin Board: CYXN), a leading manufacturer, ... today announced that it has rolled out its ... drugstores located in Changchun, Jilin. In order to ...
    ... Navigate the Safest, Most Fuel-Efficient Route and Protect Sensitive Medical ... the World,s PoorSUNNYVALE, Calif., March 16 ... Ships , the leader in using hospital ships to deliver ... the latest version of AWT,s BonVoyage System (BVS) to help ...
    ... March 16 In years past, image processing ... relied on third-party distributors to serve members of ... company,s MedicScan(R) and ScanShell(R) ( http://www.medicscan-online.com ) line ... be handling all sales inquiries, purchasing requirements, technical ...
    ... SignatureForum, an independent consumer advocacy group, is proud ... http://www.SignatureForum.com . A respected resource for people ... fitness industries, SignatureForum,s new features make it easier ... reviews of industry professionals and the specific services ...
    ... Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: ... management services, announces that Standard and Poor,s (S&P) has added ... of the Quarterly S&P/TSX Composite Index review. The change will ... , "We are very pleased with our inclusion on the ...
    ... March 16 Care Investment Trust Inc. (NYSE: ... Board of Directors has declared a dividend of $0.17 per share ... is payable on April 9, 2009 to common shareholders of record ... election of Paul F. Hughes as Chief Financial Officer and Treasurer ...
    Cached Medicine News:Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 2Health News:China Yongxin Pharmaceuticals Inc. Launches Electronic Diagnosis System in its Changchun Drugstores 3Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 2Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 3Health News:Applied Weather Technology Guides Mercy Ships With Latest BVS Marine Voyage Optimization Software 4Health News:Card Scanning Solutions Begins a New Era of Hands-On Customer Service 2Health News:SignatureForum.com Relaunches with New Ratings Features 2Health News:SXC Health Solutions Added to S&P/TSX Composite Index 2Health News:Care Investment Trust Inc. Announces Quarterly Dividend - Appoints Paul F. Hughes CFO and Treasurer 2Health News:Care Investment Trust Inc. Announces Quarterly Dividend - Appoints Paul F. Hughes CFO and Treasurer 3
    ... 3200 sets a benchmark of innovative, ... for WBC, RBC, PLT and Reticulocyte ... needs of today's laboratory. The instrument ... analysis, automated sample handling, comprehensive data ...
    ... Data Management System provides comprehensive program management ... and the Precision PCx. The QC Manager ... collect, analyze, and report quality control data ... essential laboratory tool for managing data and ...
    ... The CELL-DYN SMS consistently produces high-quality ... ensuring consistent blood films every time, eliminating ... with significantly high or low hematocrit values. ... autoloader mixes, identifies the sample, and aspirates ...
    ... The QuickVue In-Line Strep A Test allows for ... directly from patient throat swab specimens. , ,QuickVue ... and is the first strep A test waived ... rapid procedure allow testing to take place at ...
    Medicine Products: